Global and China Psoriatic Arthritis Drug Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Drug Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Other
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Drug Market Share by Application: 2020 VS 2026
1.3.2 Mild Psoriatic Arthritis
1.3.3 Moderate Psoriatic Arthritis
1.3.4 Severe Psoriatic Arthritis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis Drug Market Perspective (2015-2026)
2.2 Global Psoriatic Arthritis Drug Growth Trends by Regions
2.2.1 Psoriatic Arthritis Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psoriatic Arthritis Drug Historic Market Share by Regions (2015-2020)
2.2.3 Psoriatic Arthritis Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Drug Players by Market Size
3.1.1 Global Top Psoriatic Arthritis Drug Players by Revenue (2015-2020)
3.1.2 Global Psoriatic Arthritis Drug Revenue Market Share by Players (2015-2020)
3.2 Global Psoriatic Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis Drug Revenue
3.4 Global Psoriatic Arthritis Drug Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Drug Revenue in 2019
3.5 Key Players Psoriatic Arthritis Drug Area Served
3.6 Key Players Psoriatic Arthritis Drug Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis Drug Breakdown Data by Type (2015-2026)
4.1 Global Psoriatic Arthritis Drug Historic Market Size by Type (2015-2020)
4.2 Global Psoriatic Arthritis Drug Forecasted Market Size by Type (2021-2026)
5 Psoriatic Arthritis Drug Breakdown Data by Application (2015-2026)
5.1 Global Psoriatic Arthritis Drug Historic Market Size by Application (2015-2020)
5.2 Global Psoriatic Arthritis Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Psoriatic Arthritis Drug Market Size (2015-2026)
6.2 North America Psoriatic Arthritis Drug Market Size by Type (2015-2020)
6.3 North America Psoriatic Arthritis Drug Market Size by Application (2015-2020)
6.4 North America Psoriatic Arthritis Drug Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Drug Market Size (2015-2026)
7.2 Europe Psoriatic Arthritis Drug Market Size by Type (2015-2020)
7.3 Europe Psoriatic Arthritis Drug Market Size by Application (2015-2020)
7.4 Europe Psoriatic Arthritis Drug Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Psoriatic Arthritis Drug Market Size (2015-2026)
8.2 China Psoriatic Arthritis Drug Market Size by Type (2015-2020)
8.3 China Psoriatic Arthritis Drug Market Size by Application (2015-2020)
8.4 China Psoriatic Arthritis Drug Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Psoriatic Arthritis Drug Market Size (2015-2026)
9.2 Japan Psoriatic Arthritis Drug Market Size by Type (2015-2020)
9.3 Japan Psoriatic Arthritis Drug Market Size by Application (2015-2020)
9.4 Japan Psoriatic Arthritis Drug Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Psoriatic Arthritis Drug Market Size (2015-2026)
10.2 Southeast Asia Psoriatic Arthritis Drug Market Size by Type (2015-2020)
10.3 Southeast Asia Psoriatic Arthritis Drug Market Size by Application (2015-2020)
10.4 Southeast Asia Psoriatic Arthritis Drug Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Psoriatic Arthritis Drug Introduction
11.1.4 Abbvie Revenue in Psoriatic Arthritis Drug Business (2015-2020))
11.1.5 Abbvie Recent Development
11.2 Janssen
11.2.1 Janssen Company Details
11.2.2 Janssen Business Overview
11.2.3 Janssen Psoriatic Arthritis Drug Introduction
11.2.4 Janssen Revenue in Psoriatic Arthritis Drug Business (2015-2020)
11.2.5 Janssen Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Psoriatic Arthritis Drug Introduction
11.3.4 Amgen Revenue in Psoriatic Arthritis Drug Business (2015-2020)
11.3.5 Amgen Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Psoriatic Arthritis Drug Introduction
11.4.4 Pfizer Revenue in Psoriatic Arthritis Drug Business (2015-2020)
11.4.5 Pfizer Recent Development
11.5 Eli-lilly
11.5.1 Eli-lilly Company Details
11.5.2 Eli-lilly Business Overview
11.5.3 Eli-lilly Psoriatic Arthritis Drug Introduction
11.5.4 Eli-lilly Revenue in Psoriatic Arthritis Drug Business (2015-2020)
11.5.5 Eli-lilly Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Psoriatic Arthritis Drug Introduction
11.6.4 Celgene Revenue in Psoriatic Arthritis Drug Business (2015-2020)
11.6.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Psoriatic Arthritis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of TNF Inhibitors
Table 4. Key Players of PDE4 Inhibitors
Table 5. Key Players of Interleukin Blockers
Table 6. Key Players of Other
Table 7. Global Psoriatic Arthritis Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Psoriatic Arthritis Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Psoriatic Arthritis Drug Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Psoriatic Arthritis Drug Market Share by Regions (2015-2020)
Table 11. Global Psoriatic Arthritis Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Psoriatic Arthritis Drug Market Share by Regions (2021-2026)
Table 13. Psoriatic Arthritis Drug Market Market Trends
Table 14. Psoriatic Arthritis Drug Market Drivers
Table 15. Psoriatic Arthritis Drug Market Challenges
Table 16. Psoriatic Arthritis Drug Market Restraints
Table 17. Global Psoriatic Arthritis Drug Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Psoriatic Arthritis Drug Market Share by Players (2015-2020)
Table 19. Global Top Psoriatic Arthritis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Drug as of 2019)
Table 20. Global Psoriatic Arthritis Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriatic Arthritis Drug Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Psoriatic Arthritis Drug Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Psoriatic Arthritis Drug Market Size Share by Type (2015-2020)
Table 26. Global Psoriatic Arthritis Drug Revenue Market Share by Type (2021-2026)
Table 27. Global Psoriatic Arthritis Drug Market Size Share by Application (2015-2020)
Table 28. Global Psoriatic Arthritis Drug Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Psoriatic Arthritis Drug Market Size Share by Application (2021-2026)
Table 30. North America Psoriatic Arthritis Drug Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 32. North America Psoriatic Arthritis Drug Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 34. North America Psoriatic Arthritis Drug Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Psoriatic Arthritis Drug Market Share by Country (2015-2020)
Table 36. Europe Psoriatic Arthritis Drug Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 38. Europe Psoriatic Arthritis Drug Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 40. Europe Psoriatic Arthritis Drug Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Psoriatic Arthritis Drug Market Share by Country (2015-2020)
Table 42. China Psoriatic Arthritis Drug Market Size by Type (2015-2020) (US$ Million)
Table 43. China Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 44. China Psoriatic Arthritis Drug Market Size by Application (2015-2020) (US$ Million)
Table 45. China Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 46. China Psoriatic Arthritis Drug Market Size by Region (US$ Million) (2015-2020)
Table 47. China Psoriatic Arthritis Drug Market Share by Region (2015-2020)
Table 48. Japan Psoriatic Arthritis Drug Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 50. Japan Psoriatic Arthritis Drug Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 52. Japan Psoriatic Arthritis Drug Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Psoriatic Arthritis Drug Market Share by Country (2015-2020)
Table 54. Southeast Asia Psoriatic Arthritis Drug Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Psoriatic Arthritis Drug Market Share by Type (2015-2020)
Table 56. Southeast Asia Psoriatic Arthritis Drug Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Psoriatic Arthritis Drug Market Share by Application (2015-2020)
Table 58. Southeast Asia Psoriatic Arthritis Drug Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Psoriatic Arthritis Drug Market Share by Country (2015-2020)
Table 60. Abbvie Company Details
Table 61. Abbvie Business Overview
Table 62. Abbvie Product
Table 63. Abbvie Revenue in Psoriatic Arthritis Drug Business (2015-2020) (US$ Million)
Table 64. Abbvie Recent Development
Table 65. Janssen Company Details
Table 66. Janssen Business Overview
Table 67. Janssen Product
Table 68. Janssen Revenue in Psoriatic Arthritis Drug Business (2015-2020) (US$ Million)
Table 69. Janssen Recent Development
Table 70. Amgen Company Details
Table 71. Amgen Business Overview
Table 72. Amgen Product
Table 73. Amgen Revenue in Psoriatic Arthritis Drug Business (2015-2020) (US$ Million)
Table 74. Amgen Recent Development
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Psoriatic Arthritis Drug Business (2015-2020) (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Eli-lilly Company Details
Table 81. Eli-lilly Business Overview
Table 82. Eli-lilly Product
Table 83. Eli-lilly Revenue in Psoriatic Arthritis Drug Business (2015-2020) (US$ Million)
Table 84. Eli-lilly Recent Development
Table 85. Celgene Company Details
Table 86. Celgene Business Overview
Table 87. Celgene Product
Table 88. Celgene Revenue in Psoriatic Arthritis Drug Business (2015-2020) (US$ Million)
Table 89. Celgene Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Psoriatic Arthritis Drug Market Share by Type: 2020 VS 2026
Figure 2. TNF Inhibitors Features
Figure 3. PDE4 Inhibitors Features
Figure 4. Interleukin Blockers Features
Figure 5. Other Features
Figure 6. Global Psoriatic Arthritis Drug Market Share by Application: 2020 VS 2026
Figure 7. Mild Psoriatic Arthritis Case Studies
Figure 8. Moderate Psoriatic Arthritis Case Studies
Figure 9. Severe Psoriatic Arthritis Case Studies
Figure 10. Psoriatic Arthritis Drug Report Years Considered
Figure 11. Global Psoriatic Arthritis Drug Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Psoriatic Arthritis Drug Market Share by Regions: 2020 VS 2026
Figure 13. Global Psoriatic Arthritis Drug Market Share by Regions (2021-2026)
Figure 14. Global Psoriatic Arthritis Drug Market Share by Players in 2019
Figure 15. Global Top Psoriatic Arthritis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Drug as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Drug Revenue in 2019
Figure 17. North America Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Psoriatic Arthritis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Abbvie Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 45. Janssen Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 46. Amgen Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 47. Pfizer Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 48. Eli-lilly Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 49. Celgene Revenue Growth Rate in Psoriatic Arthritis Drug Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed